AngioDynamics, Inc. - Common Stock (NQ:ANGO)

11.23 -2.96 (-20.86%)

Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

51 Biggest Movers From Friday ↗

October 18, 2021

Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

October 15, 2021

Cowen & Co. lowered the price target on Domino's Pizza, Inc. (NYSE:

Via Benzinga

Mid-Afternoon Market Update: Gold Rises 2%; Bed Bath & Beyond Shares Slide ↗

September 30, 2021

Toward the end of trading Thursday, the Dow traded down 0.74% to 34,136.80 while the NASDAQ rose 0.36% to 14,565.16. The S&P also fell, dropping 0.25% to 4,348.69. The U.S....

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For October 15, 2021 ↗

October 15, 2021

Upgrades B of A Securities upgraded the previous rating for WEC Energy Group Inc (NYSE:

Via Benzinga

Investors Cheer AngioDynamics' Q1 Beat, Raised FY22 Sales Outlook ↗

September 30, 2021

AngioDynamics Inc (NASDAQ: ANGO) reported a Q1 FY22 adjusted EPS loss of $(0.02), ahead of the consensus of $(0.04). Q1 sales increased 9.6% Y/Y to $77...

Via Benzinga

51 Biggest Movers From Yesterday ↗

October 01, 2021

Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 30, 2021

Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current volume of 70.4 million shares is 943.37% of Progenity...

Via Benzinga

Mid-Day Market Update: Dow Drops Over 300 Points; Virgin Galactic Shares Jump ↗

September 30, 2021

Midway through trading Thursday, the Dow traded down 0.97% to 34,056.76 while the NASDAQ fell 0.09% to 14,499.45. The S&P also fell, dropping 0.58% to 4,334.04. The U.S. has...

Via Benzinga

Topics Stocks

36 Stocks Moving In Thursday's Mid-Day Session ↗

September 30, 2021

Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 55% to $13.00. Paltalk engaged ClearThink to lead expanded investor relations program. Farmmi, Inc. (NASDAQ: FAMI) jumped 45.5...

Via Benzinga

Angiodynamics Inc (ANGO) Q1 2022 Earnings Call Transcript ↗

September 30, 2021

ANGO earnings call for the period ending August 31, 2021.

Via The Motley Fool

Topics Earnings

Mid-Morning Market Update: Markets Mixed; CarMax Profit Misses Views ↗

September 30, 2021

Following the market opening Thursday, the Dow traded down 0.11% to 34,352.56 while the NASDAQ climbed 0.44% to 14,576.37. The S&P also rose, gaining 0.15% to 4,365.81. The U....

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug ↗

September 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...

Via Benzinga

AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance

September 30, 2021

From AngioDynamics, Inc.

Via Business Wire

Earnings Scheduled For September 30, 2021 ↗

September 30, 2021

Companies Reporting Before The Bell • Antelope Enterprise Hldgs (NASDAQ:AEHL) is likely to report earnings for its first quarter. • Paychex (NASDAQ:PAYX) is...

Via Benzinga

AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021

September 15, 2021

From AngioDynamics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 20, 2021 ↗

August 20, 2021

Upgrades For Investors Bancorp Inc (NASDAQ:

Via Benzinga

AngioDynamics to Present at the Canaccord Genuity Virtual Growth Conference

July 29, 2021

From AngioDynamics, Inc.

Via Business Wire

After Beating Estimates, Is This Little-Known Medical Device Company a Buy? ↗

July 18, 2021

AngioDynamics exceeded analyst expectations on revenue in Q4 2021, but does that make it worth buying?

Via The Motley Fool

Angiodynamics Inc (ANGO) Q4 2021 Earnings Call Transcript ↗

July 13, 2021

ANGO earnings call for the period ending May 31, 2021.

Via The Motley Fool

Topics Earnings

AngioDynamics Breaks-Even In FY21, Issues Mixed Forecasts For FY22 ↗

July 13, 2021

AngioDynamics Inc (NASDAQ: ANGO) reports break-even in 4Q of 2021 with adjusted EPS of $0.00, a turnaround from EPS of (0.06) posted a year ago. The Company...

Via Benzinga

AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results

July 13, 2021

From AngioDynamics, Inc.

Via Business Wire

The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues ↗

July 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...

Via Benzinga

Earnings Scheduled For July 13, 2021 ↗

July 13, 2021

Companies Reporting Before The Bell • OrganiGram Holdings (NASDAQ:OGI) is estimated to report quarterly loss at $0.03 per share on revenue of $13.95 million. •...

Via Benzinga

The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data ↗

July 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix ↗

July 11, 2021

Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback...

Via Benzinga

AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021

July 08, 2021

From AngioDynamics, Inc.

Via Business Wire

The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs ↗

June 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021

June 24, 2021

From AngioDynamics, Inc.

Via Business Wire

The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗

June 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway ↗

June 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.